Developement and Validation of the Health Behavior Questionnaire Towards Deprescribing (HBQtD)
Launched by UNIVERSITÉ CATHOLIQUE DE LOUVAIN · Jan 8, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Health Behavior Questionnaire Towards Deprescribing (HBQtD), aims to create and test a new questionnaire that will help understand how older adults and their caregivers decide if they should stop taking certain medications. Researchers want to find out what influences these decisions, including factors like health literacy (how well someone can understand health information) and locus of control (how much control they feel they have over their health).
To participate, older adults must be at least 60 years old, take five or more medications daily, and have at least one chronic condition. Informal caregivers, who help manage the health and medications of these older adults, are also welcome to join. Participants will complete the new questionnaire along with two additional surveys to help ensure the questionnaire is effective. This study is currently recruiting participants, and it provides an opportunity to contribute to important research that could improve medication management for older adults in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Older adults
- • Age 60 years or older;
- • Taking at least 5 medications daily;
- • Having at least one chronic condition.
- • Informal caregivers
- • They self-identified as a caregiver (defined as having any role in a family member or friend's management of health and/ or medication management) of an older adult who has 60 years old or older, that are taking at least 5 medications daily;
- • The care recipient lived in the community (at home with or without the caregiver) or in a NH.
- Exclusion Criteria:
- • Older adults
- • Suffering from psychiatric trouble;
- • Past or present drug or alcohol dependency;
- • Having a terminal illness;
- • Inability to complete a written questionnaire in French due to a functional or cognitive impairment;
- • Inability to understand and express oneself in French.
- • Informal cariegivers
- • Caregiver age under 18 years old;
- • Caregivers who are paid for the care they provide;
- • Caregiver inability to give consent and complete a written questionnaire in French;
- • Caregiver inability to understand and speak in French.
About Université Catholique De Louvain
Université Catholique de Louvain (UCLouvain) is a prestigious Belgian institution renowned for its commitment to academic excellence, research innovation, and interdisciplinary collaboration. With a strong emphasis on advancing medical science and improving patient outcomes, UCLouvain conducts a range of clinical trials across various medical fields. The university's research initiatives are supported by cutting-edge facilities and a team of experienced professionals, fostering a robust environment for clinical investigation. UCLouvain is dedicated to ethical research practices and aims to contribute significantly to the global body of medical knowledge through its clinical trial endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Louvain La Neuve, , Belgium
Patients applied
Trial Officials
Stephan Van den Broucke, PhD
Principal Investigator
Université Catholique de Louvain
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported